SELLAS Life Sciences Group (SLS) has shared an update.
SELLAS Life Sciences Group, Inc. is undergoing significant executive restructuring, with the termination of Barbara A. Wood, the Executive Vice President, and Robert Francomano, the Senior Vice President, both without cause. The company is arranging separation agreements with the outgoing executives and has announced a strategic reorganization focusing on commercialization partnerships to steer the company towards future growth. Details on the agreements will be shared once finalized.
For a thorough assessment of SLS stock, go to TipRanks’ Stock Analysis page.
